Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
New clues about vitamin D functions in the nervous system
2002708 citationsEmmanuel Garcion, N. Wion-Barbot et al.Trends in Endocrinology and Metabolismprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by N. Wion-Barbot
Since
Specialization
Citations
This map shows the geographic impact of N. Wion-Barbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Wion-Barbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Wion-Barbot more than expected).
This network shows the impact of papers produced by N. Wion-Barbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Wion-Barbot. The network helps show where N. Wion-Barbot may publish in the future.
Co-authorship network of co-authors of N. Wion-Barbot
This figure shows the co-authorship network connecting the top 25 collaborators of N. Wion-Barbot.
A scholar is included among the top collaborators of N. Wion-Barbot based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with N. Wion-Barbot. N. Wion-Barbot is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Halimi, S., et al.. (2003). [Self-monitoring of blood glucose in type 2 diabetic patients. What could we propose according to their treatment?].. PubMed. 29(2 Pt 2). S26–30.5 indexed citations
7.
Garcion, Emmanuel, N. Wion-Barbot, Claudia N. Montero‐Menei, François Berger, & Didier Wion. (2002). New clues about vitamin D functions in the nervous system. Trends in Endocrinology and Metabolism. 13(3). 100–105.708 indexed citations breakdown →
Wion-Barbot, N., Isabelle Schuffenecker, Patricia Niccoli, et al.. (1997). Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.. PubMed. 58(4). 302–8.25 indexed citations
11.
Niccoli, Patricia, B. Conte‐Devolx, P.J. Lejeune, et al.. (1996). [Hypercalcitoninemia in conditions other than medullary cancers of the thyroid].. PubMed. 57(1). 15–21.27 indexed citations
12.
Vuillemin, E., et al.. (1996). [Turner syndrome and digestive telangiectasis: an additional value of estrogen-progestational treatment].. PubMed. 20(5). 510–1.1 indexed citations
13.
Guyétant, Serge, Marie‐Christine Rousselet, N. Wion-Barbot, et al.. (1995). [Hyperthyroidism induced by amiodarone and hyperthyroidism induced by iodine. Histologic, immunohistochemical and ultrastructural aspects].. PubMed. 15(6). 431–7.5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.